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A large proportion of intracellular Sendai virus (SeV) M proteins is phosphorylated, but in mature virions the M protein
is not phosphorylated or dephosphorylated. Phosphorylated M protein in cells is bound to the cytoskeletal components
more firmly than unphosphorylated M protein. Thus it has been hypothesized that M protein phosphorylation plays an
important role in the virus life cycle, especially in the step of maturation. Here, a transient expression-mutation experiment
of the M gene demonstrated that a change of the Ser residue at the 70th position from the N-terminus to Ala (S70A) totally
abolished M protein phosphorylation, strongly suggesting that this residue is phosphorylated. The mutated M gene was
then placed in the corresponding region in the cDNA plasmid which generates a full-length antigenome SeV RNA, and a
mutant SeV M-S70A was successfully recovered from the cDNA. This mutant virus was indeed defective in M protein
phosphorylation but did not differ at all from the wild-type SeV recovered from the parental cDNA either in the replication
kinetics and plaque morphology in cultured cells or in in vivo replication and pathogenicity for mice. We thus concluded
that no phosphorylation of the M protein was required for SeV replication either in vitro or in vivo. q 1997 Academic Press
INTRODUCTION F and HN glycoproteins (Sanderson et al., 1993, 1994),
or alternatively, it may be its intrinsic nature to bind to the
The viruses in the superfamily Mononegavirales, com-
inner leaflet of the lipid bilayer and/or to the cytoskeletal
prising three families, Paramyxoviridae, Rhabdoviridae,
components (Stricker et al., 1994). Mottet et al. (1996)and Filoviridae, are characterized by a nonsegmented
demonstrated by trans-supplying mutant M genes asnegative-sense RNA genome and a lipid envelope of the
minigenomes that the membrane association of the Mvirion surface. Late in their life cycle, viral components
protein was indeed necessary for efficient virus budding.such as envelope glycoproteins, viral matrix, or mem-
The M proteins form paracrystalline arrays by the M– Mbrane (M) proteins and ribonucleocapsids assemble at
interaction at the inner side of the plasma membranethe plasma membrane, and subsequently the progeny
in virus-infected cells (Ba¨chi, 1980). How the M proteinvirus enwrapped by an envelope is formed by budding.
recognizes the nucleocapsid has not been well under-The M protein is one of the most abundant protein spe-
stood. However, the association between the M proteincies in the virion and forms a layer underlying the viral
and the nucleocapsids has been shown by chemicalenvelope. Thus, the M protein appears to be able to
cross-linking, and by virion fractionation and reconstitu-recognize both the envelope and the inner ribonucleo-
tion studies (Markwell and Fox, 1980; Nagai et al., 1978;capsid core and somehow provide the force to drive virus
Yoshida et al., 1976).assembly and budding (reviewed in Matsumoto, 1982;
A large portion of Sendai virus (SeV) M protein is phos-Peeples, 1991).
phorylated in infected cells, but not in mature virions,Pulse–chase studies have demonstrated that immedi-
suggesting the possibility that the phosphorylated M isately after synthesis the bulk of paramyxovirus M pro-
selectively eliminated from progeny virions in the bud-teins binds to the area of the plasma membrane that
ding process or that M is dephosphorylated during virusalready contains the glycoproteins (Nagai et al., 1976).
assembly (Lamb and Choppin, 1977). Sanderson et al.The M protein association with the cellular membrane
(1995) showed by using Triton X-100 and high salt extrac-could be mediated by its direct interaction with the viral
tion that the phosphorylated M protein binds to cytoskel-
etal components more firmly than the unphosphorylated1 To whom correspondence and reprint requests should be ad-
M. Kim and Kamata (1994) reported growth impairmentdressed. Fax: /81-82-257-5159. E-mail: takemasa@mcai.med.hiro
shima-u.ac.jp. of SeV in LLC-MK2 cells maintained in a low CaCl2 me-
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dium. In the latter, the intracellular distribution of the M Nickoloff, 1992), as described in the U.S.E. mutagenesis
protocols of Pharmacia-LKB, Inc. (Uppsala, Sweden). Theprotein was abnormal and, at the same time, phosphory-
lation of the M protein was enhanced. These studies nucleotide sequences of the altered cDNA were con-
firmed.suggest that M protein phosphorylation is linked to the
functions of M and plays an important role in the SeV
Protein expression in mammalian cells, metaboliclife cycle.
labeling, immunoprecipitation, and SDS–PAGEAll of the above described features of paramyxovirus
M protein have been revealed by using conventional bio-
Subconfluent monolayers of LLC-MK2 cells in a 3.5-cmchemical and cell biological procedures, including tran-
dish were infected with vaccinia virus vTF7.3 at an m.o.i.
sient expression of a single gene encoding the M protein
of 10 PFU/cell and transfected with plasmid DNA by us-
and its derivatives. They may individually depict certain
ing the LipofectACE Reagent (Gibco-BRL Life Technolo-
aspects of the virus life cycle but their significance re-
gies, Gaithersburg, MD). At 5 hr posttransfection, the
mains yet to be verified in the context of virus reproduc-
cells were labeled with [35S]Pro-Mix (100 mCi/ml; Amer-
tion not only in in vitro cells but also in in vivo natural
cham International, Arlington Heights, IL) in methionine-
hosts. In this paper, we have focused on the phosphory-
and cysteine-free medium. The cells were lysed in radio-
lation of SeV M protein and studied its significance for
immunoprecipitation assay (RIPA) buffer [10 mM Tris–
virus replication both in vitro and in vivo by utilizing the
HCl, pH 7.4, 1% Triton X-100, 1% sodium deoxycholate,
SeV technology which allows virus recovery entirely from
0.1% sodium dodecyl sulfate (SDS), 150 mM NaCl, and
cDNA and hence reverse genetics (Kato et al., 1996). We
1 mM PMSF (phenylmethanesulfonyl fluoride; Sigma
first defined the actual residue to be phosphorylated in
Chemical Co., St. Louis, MO)]. For [32P]orthophosphate
SeV M protein and then created a virus in which the
labeling, the transfected cells were washed with phos-
residue was mutated so that the viral M protein under-
phate-free medium at 3 hr posttransfection and incu-
went no phosphorylation. This mutation has so far
bated in the medium for 2 hr. Cells were then incubated
caused no phenotypic change either in vitro or in vivo,
with 0.3 mCi/ml [32P]orthophosphate (Amercham) in
strongly suggesting that there is no absolute requirement
phosphate-free medium and lysed in RIPA buffer con-
for M protein phosphorylation for any step in the virus
taining phophatase inhibitors (50 mM sodium fluoride, 25
life cycle.
mM glycerophosphate, 2 mM EDTA, and 200 mM sodium
vanadate; Sigma). Polypeptides were immunoprecipi-
MATERIALS AND METHODS tated with anti-SeV serum and analyzed by 10% SDS–
polyacrylamide gel electrophoresis (PAGE) as describedCells and viruses
previously (Sakaguchi et al., 1996). Radioactivity was an-
LLC-MK2 cells were grown in Eagle’s minimal essential alyzed by using a Fujix BAS 2000 image analyzer (Fuji
medium (MEM) supplemented with 5% newborn calf se- Photo Film, Tokyo, Japan).
rum, and CV1 cells were grown in MEM supplemented
with 10% fetal calf serum. SeV Z strain was propagated Recovery of SeV from cDNA
in 10-day-old embryonated chicken eggs. The infectivity
A fragment of a mutant M cDNA, which contains 98%of SeV was titrated with an immunofluorescent infectious
of the coding frame of M protein, was cut out from pGEM-focus assay (Kashiwazaki et al., 1965), with some modifi-
M by digesiton with EcoRV and partial digestion withcations (Kiyotani et al., 1990), and expressed as cell infec-
ApaLI and replaced with the corresponding fragment oftious units (CIU)/ml. Recombinant vaccinia virus vTF7.3,
pSeV(/) containing the whole anti-genomic cDNA of thewhich contains the bacteriophage T7 RNA polymerase
Se V Z strain, generating pSeV(/) M-S70A. SeV was re-gene (Fuerst et al., 1986), was provided by Dr. Bernard
covered from this cDNA as described by Kato et al.Moss (National Institutes of Health, Bethesda, MD).
(1996). Briefly, 1.2 1 107 of LLC-MK2 cells in a 6-cm dish
were infected with VTF7.3 at an m.o.i. of 2 PFU/cell andConstruction of plasmids, and site-specific
transfected with pSeV(/) M-S70A (10 mg) and the plas-mutagenesis
mids encoding trans-acting proteins, pGEM-N (5 mg),
pGEM-P (2.5 mg), and pGEM-L (5 mg) with the aid ofThe M cDNA of SeV Z strain (Sakaguchi et al., 1993),
which was generated from genomic clones of SeV kindly a liposomal transfection reagent, DOTAP (Boehringer-
Mannheim, Mannheim, Germany). The cells were thenprovided by Dr. Shioda and the late Dr. Shibuta (Univer-
sity of Tokyo, Japan; Hidaka et al., 1984), was inserted maintained in MEM containing 40 mg/ml of cytosine b-
D-arabinofuranoside (Ara-C; Sigma) and 100 mg/ml of ri-into the downstream of T7 promoter of the pGEM3 vector
(Promega Corp., Madison, WI), generating pGEM-M. Site- fampicin (Sigma) to minimize vaccinia virus cytopathoge-
nicity and maximize the recovery rate. After 2 days, thespecific mutagenesis of pGEM-M was performed using
the unique site elimination (U.S.E.) system (Deng and cells were suspended in 1 ml of Dulbecco’s phosphate-
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buffered saline (PBS) and disrupted by three cycles of
freezing and thawing. The cell lysates were inoculated
to 10-day-old embryonated chicken eggs.
In vitro phosphorylation of SeV M using virions
In vitro phosphorylation of SeV M was performed es-
sentially according to the method of Lamb (1975). SeV
virions were purified using discontinuous sucrose gradi-
ent and ultra-centrifugation. Purified virions (100 mg)
were suspended in 200 ml of a reaction buffer containing
0.1% Triton X-100, 25 mM Tris–HCl, pH 8.0, 10 mM dithio-
threitol, 20 mM MgCl2 , and 100 mM NaCl. The mixture
was incubated with or without 2 mM ATP at 367 for 60
min. The reaction was stopped by boiling with an equal
amount of 21 SDS–PAGE sample buffer. The polypep-
tides were analyzed by 10% SDS–PAGE and were
stained with Coomassie brilliant blue R-250.
Infection of mice with SeV
Specific pathogen-free, 3-week-old male mice of the
ICR/Crj (CD-1) strain weighing 8 to 11 g and purchased
from Charles River Japan, Inc. (Atsugi, Japan) were inocu- FIG. 1. (A) Nucleotide and deduced amino acid sequences of M-
lated with SeV samples (25 ml) intranasally under mild S70A cDNA. The mutation and the deduced amino acid sequence of
M-S70A are shown in comparison with the wild-type (wt) M protein.ether anesthesia. They were kept under bioclean condi-
Identical residues are shown by asterisks. The nucleotide sequencetions at 227 and 55% humidity throughout the experi-
is numbered so that the beginning residue of the coding frame ofments. At intervals, the body weight and clinical signs
the M protein is one. (B) The mutant M-S70A protein is deficient in
of the animals were checked. Some of the mice were phosphorylation when expressed from cDNA. The mutant M-S70A and
sacrificed on the second day after infection, and lungs wild-type (wt) M proteins were expressed in LLC-MK2 cells by using
the Vac/T7 expression system in a duplicate manner. At 5.5 hr post-from each mouse were homogenized in 1 ml MEM using
transfection, one set of the cells was metabolically labeled with [32P]-a pestle and mortar and clarified by low speed centrifuga-
orthophosphate. Proteins were immunoprecipitated with anti-SeV anti-tion. The supernatant was used for measurement of virus
sera and analyzed by 10% SDS–PAGE under reducing conditions. The
infectivity. The 50% lethal dose endpoints (LD50) were cells were infected with SeV Z strain and processed in the same way
calculated as described (Kiyotani et al., 1990). for a protein size marker (SeV).
RESULTS AND DISCUSSION cells, are shown in Fig. 1 in comparison with those of
the wild-type M protein (M wt). Labeling with [32P]-Identification of the phosphate-accepting serine
orthophosphate in LLC-MK2 cells revealed the lack ofresidue in SeV M protein and its mutation
phosphate incorporation to M-S70A (Fig. 1B). Another set
SeV M protein is known to be modified by the addition of simultaneously transfected cells labeled with 35S-Cys
of phosphates to Ser residues (Lamb and Choppin, 1977). and -Met for 30 min and incubated in chase medium for
A protein functional motif search program, the PROSITE 60 min to allow M protein maturation (de Melo et al.,
database search (Fuchs, 1994), against the deduced 1992; Sheshberadaran and Lamb, 1991) revealed the
amino acid sequence of the M protein of the SeV Z strain presence of authentic unphosphorylated M protein and
indicated four Ser residues potentially phosphorylated the absence of the B band, representing the phosphory-
with casein kinase II (the 11th, 70th, and 253rd residues lated M (Lamb and Choppin, 1977; Fig. 1B). When 4 M
from the N-terminus of the M protein) and with protein urea was included in the gel, the B band disappeared,
kinase C (the 138th residue). In pGEM-M plasmid, each comigrating with the M band (not shown). This also indi-
of these sites was mutated to encode Ala instead of Ser, cates that the B band represents the phosphorylated
and the resulting plasmids were transfected to the LLC- species (Lamb and Choppin, 1977). These data strongly
MK2 cells and examined for phosphorylation of the ex- suggest that the 70th Ser residue is a phosphate ac-
pressed M proteins. ceptor. Similar mutation-expression studies were carried
The mutation at the 70th residue and the deduced out for the other three potential acceptor Ser residues at
amino acid change of the mutant (M-S70A), plus the met- positions 11, 138, and 253. None of them was found to
be dephosphorylated (data not shown).abolic labeling pattern of the gene product in LLC-MK2
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TABLE 1 the incubation of the virions with ATP, dithiothreitol,
MgCl2 , and a mild detergent (Lamb, 1975). This was con-Recovery of SeV from the Mutant and Parental cDNA Plasmids
firmed for our purified wild-type SeV by the appearance
Inoculum Virus yield of the B band, representing the phosphorylated form of
size SeV M protein (Fig. 2B). In contrast, no such band
Transfectant (cell number) HAU CIU/ml emerged with the mutant SeV M-S70A under the same
conditions (Fig. 2B). These results unequivocally demon-pSeV(/) M-S70A 106 512 2.2 1 109
strated the successful isolation of a SeV mutant defective105 128*, 256 9.4 1 108*, 1.7 1 108
(512) (2.7 1 1010) in M protein phosphorylation. The virus recovery rate
104 128, 4 5.3 1 108, 103… from transfected LLC-MK2 cells, the virus titers reached
pSeV(/) 106 64 2.9 1 108 after amplification in eggs, and the level of protein syn-
105 512*, 256 2.9 1 109*, 3.6 1 109
thesis in cells were all comparable between the wild-(1024) (1.6 1 1010)
type and the phosphorylation(0) mutant. This suggests104 4, 4 103, 103
pUC19 106 4 103 the nonrequirement of M protein phosphorylation for SeV
replication in the host systems, including LLC-MK2 cells
Note. The mutant plasmid pSeV(/) M-S70A, the parental plasmid and embryonated chicken eggs.
pSeV(/), or mock plasmid pUC19 was transfected to LLC-MK2 cells to
recover infectious virus as described under Materials and Methods.
Further characterization of the SeV mutantTransfected cells were inoculated into embryonated chicken eggs after
three cycles of freezing and thawing. After a 3-day incubation, the
LLC-MK2 cells were infected with SeV M-S70A or theallantoic fluid of each egg was harvested and individually determined
wild-type SeV at an m.o.i. of 20 CIU/cell, and their singlefor hemagglutinating units (HAU) and infectivity (CIU/ml). The viruses
from one (*) of the eggs were diluted and inoculated into eggs again growth kinetics were compared. There were no apprecia-
to obtain the helper vaccinia virus-free SeV stock. The HAU and infectiv- ble differences between the two viruses (Fig. 3A). There
ity of these stock viruses are shown in parentheses. were no differences, either, when their infections were
compared under multiple cycle growth conditions, begin-
Creation of a SeV mutant defective in M protein
phosphorylation
The plasmid pSeV(/) generates a full-length anti-
genome SeV RNA and has been used as the template
to initiate an infectious cycle in the SeV rescue system
(Kato et al., 1996). The EcoRV–ApaLI region in this plas-
mid, accounting for 98% of the M protein coding region,
was replaced with the corresponding fragment derived
from the pGEM-M S70A. Subconfluent LLC-MK2 cells
were infected with vTF7.3 and then transfected with this
new plasmid pSeV(/) M S70A and with the three sup-
porting plasmids, pGEM-N, pGEM-P, and pGEM-L. After
a 48-hr incubation, the cells were freeze-thawed three
times and injected into embryonated chicken eggs for
amplification of the recovered virus. As shown in Table
1, SeV M-S70A was successfully recovered from 105 or
more transfected cells, and in one case from 104 trans-
fected cells. This efficiency of virus recovery was well
comparable to that from the parental plasmid pSeV(/). FIG. 2. (A) The recovered mutant SeV M-S70A lacks phosphorylation
in the M protein. LLC-MK2 cells were infected with SeV M-S70A (M-The viruses were passaged once again in eggs at a
S70A) or the wild-type (wt) at an m.o.i. of 30 and metabolically labeledhigh dilution (1007) to eliminate the helper vaccinia virus
either with a mixture of 35S-Cys and -Met or with [32P]orthophosphatepresent in an amount of about 104 PFU/ml and used as
as described in the legend to Fig. 1B. Proteins were immunoprecipi-
stocks for all the subsequent experiments. tated with anti-SeV antisera and analyzed by 10% SDS–PAGE under
Sequencing of the M gene of the recovered SeV M- reducing conditions. (B) In vitro phosphorylation reaction using purified
virions. SeV particles were prepared in embryonated eggs and purifiedS70A confirmed the preservation of the introduced muta-
by ultracentrifugation in a discontinuous sucrose gradient. Purified viri-tions. Metabolic labeling followed by SDS–PAGE clearly
ons (100 mg) of SeV M-S70A or the wild-type (wt) were suspended indemonstrated the phosphorylation-negative phenotype
a 200-ml reaction mixture containing 0.1% Triton X-100, 20 mM MgCl2 ,for the mutant virus M protein (Fig. 2A). The unphosphory- and 10 mM dithiothreitol, and incubated at 377 for 60 min in the pres-
lated M protein in the SeV virions was found to be phos- ence (/) or absence (0) of 2 mM ATP. The proteins were analyzed by
10% SDS–PAGE and stained with Coomassie brilliant blue R-250.phorylated in vitro by a virion-associated kinase following
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FIG. 3. Replication kinetics of SeV M-S70A and the wild-type in cultured cells. (A) Confluent LLC-MK2 cells in a 6-cm dish were infected with
SeV M-S70A or the wild-type (wt) at an m.o.i. of 20 CIU/cell in duplicate and maintained in 5 ml MEM. At intervals, a 250-ml aliquot of the medium
was harvested and clarified by low speed centrifugation. The mean titers of hemagglutinating units and infectivity (CIU/ml) of the media are shown
by bars and lines, respectively. Standard deviation of the infectivity is shown by a vertical line. (B) LLC-MK2 cells were infected with SeV M-S70A
or the wild-type at an m.o.i. of 0.001 CIU/cell in duplicate and maintained in 5 ml MEM with 10mg/ml of trypsin. (C) Plaque appearance of SeV M-
S70A and SeV wt. Confluent CV1 cells were infected with the mutant or wild-type SeV, and plaques formed were stained with amido black.
ning with a low inoculum dose (Fig. 3B). Exactly the same (LD50), 5.61 106 CIU/mouse, since the 107 CIU-inoculated
mice all died and the 105 CIU-inoculated mice all sur-observations were made in another cell line, CV1, with
respect to growth kinetics under single- and multi-cycle vived. Moreover, the virus titers in the lung 2 days after
infection, when the wild-type virus reaches a peak titerconditions (data not shown). In addition, there were no
appreciable differences in plaque size and morphology (Kiyotani et al., 1990), were very similar at 4.0–4.1 1 107
and 3.7–4.3 1 107 CIU/ml of the lung homogenate forfor the mutant and wild-type virus either in CV1 cells (Fig.
3C) or LLC-MK2 cells (data not shown). These results SeV M-S70A and the wild-type, respectively. The phos-
phorylation negative phenotype had been maintained inindicate that abolishment of M protein phosphorylation
does not affect the capability of SeV to replicate in at the S70A virus recovered from the lungs (data not
shown). These results indicate that abolishment of Mleast two arbitrarily chosen culture cell lines.
Mice are the natural host of SeV. There are a number protein phosphorylation resulted in neither attenuation
nor potentiation in SeV replication and pathogenicity inof viral genes that are known to be nonessential for viral
replication in cultured cells but play a critical role in in vivo.
Finally, to ascertain the stability of the phenotype, wevivo replication and pathogenesis. The nonessential SeV
V gene is one such case, which has recently been dem- performed five successive blind passages of SeV M-
S70A. Each passage was initiated with 300 CIU/egg andonstrated to be required for maintaining a high viral load
in the mouse lung to ultimately cause severe pneumonia harvested with a final titer of 1010 CIU/egg, so that the
virus underwent numerous rounds of replication even(Kato et al., 1997). Thus, we were interested in learning
whether the phosphorylation mutation could cause any within a single passage. We found that the phosphoryla-
tion-negative phenotype was stably maintained after fiveviral phenotypic change in mice. As shown in Fig. 4, the
mutant and wild-type viruses similarly disturbed body passages (data not shown).
We defined the phosphate-accepting serine residueweight gain following infection initiated by 106 CIU/
mouse, and gave an identical 50% lethal inoculation dose (the 70th residue from the N-terminus) in the M protein
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FIG. 4. Body weight gain of the mice infected with SeV M-S70A or the wild type. Four 3-week-old male mice of the ICR/Crj (CD-1) strain were
intranasally inoculated with 1 1 106 CIU/mouse of SeV M-S70A or SeV wt, and body weight was measured every day during 2 weeks. Mock-infected
mice were inoculated with PBS. The dagger (†) indicates death of the mouse.
University School of Medicine, for the use of their facilities. This workof SeV, and were able to recover a mutant virus that had
was partly supported by a grant-in-aid from the Ministry of Education,undergone a change of this residue (Ser to Ala) and
Science and Culture of Japan.
was totally defective in M protein phosphorylation. This
mutation was found to affect none of the viral phenotypes
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